|
Referenzen
1 Göke B, Gamba S, Erdtsieck RJ, Gilbey S, Schober E, Lytzen L, Kolaczynski M. NovoPen® 4 offers superior performance, handling and acceptance compared with NovoPen® 3 in insulin-treated diabetes patients. Diabetes Technol Ther. 2005 Apr; 7(2): 379.
2 Kolaczynski M, Chayer D. NovoPen® 4: perceived as superior in handling and acceptance versus HumaPen® Ergo and OptiPen® Pro in patients and healthcare professionals. Diabetes Technol Ther. 2005 Apr; 7(2): 390.
|